ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C. (Q50558380)
Jump to navigation
Jump to search
scientific article published in November 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C. |
scientific article published in November 2010 |
Statements
ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C. (English)
1 reference
Naoya Sakamoto
1 reference
Yasuhito Tanaka
1 reference
Mina Nakagawa
1 reference
Hiroshi Yatsuhashi
1 reference
Shuhei Nishiguchi
1 reference
Nobuyuki Enomoto
1 reference
Seishin Azuma
1 reference
Yuki Nishimura-Sakurai
1 reference
Sei Kakinuma
1 reference
Nao Nishida
1 reference
Katsushi Tokunaga
1 reference
Masao Honda
1 reference
Kiyoaki Ito
1 reference
Masashi Mizokami
1 reference
Mamoru Watanabe
1 reference
1 November 2010
1 reference
40
1 reference
11
1 reference
1063-1071
1 reference
1 reference